Rights Contact Login For More Details
- Wiley
More About This Title Novartis Foundation Symposium 282 - DietarySupplements and Health
- English
English
On a global basis, the dietary supplement industry has enjoyed rapid growth, becoming a multi-billion dollar enterprise over the last 10 years. This growth has been associated with significant changes in both the types of products available and the reasons for using these products.
In many cases, these changes have occurred without the benefit of a sound scientific basis for evaluating the safety and efficacy of these products under the new conditions of use and frequently the same limited scientific evidence is used, even though current product composition, user populations, purported beneficial effects, and conditions of use may differ significantly from the available evidence or historical usage.
This book presents systematic examinations of the scientific data that are available and/or needed to substantiate and evaluate the safety and efficacy of dietary supplements. A series of case studies that are illustrative of the types of scientific challenges that have been encountered in substantiating safety and efficacy for various product types are employed to point out some of the successes but also frustrations that have occurred in recent years. Discussions among presenters and participants identify the lessons learned from these experiences and formulate ideas for improved approaches to identifying research needs and for enhancing the quality and relevance of the scientific evidence available for policy decisions.
Dietary Supplements and Health constitutes a useful resource for nutritionists, biochemists, public health researchers and anyone interested in herbal, alternative medicines.
- English
English
- English
English
9–11 May 2006
Editors: Gregory Bock (Organizer) and Jamie Goode
This symposium is based on a proposal made by Barry Halliwell, Paul Coates and
Elizabeth Yetley
Barry Halliwell Chair’s introduction
Alan R. Boobis Risk assessment of dietary supplements
Discussion
Robert M. Russell Setting dietary intake levels: problems and pitfalls
Discussion
Peter J. Aggett Criteria for substantiating claims
Discussion
Elizabeth A. Yetley Science in the regulatory setting: a challenging but
incompatible mix?
Discussion
Roland Stocker Vitamin E
Discussion
Barry Halliwell Flavonoids: a re-run of the carotenoids story?
Discussion
John M. Scott Reduced folate status is common and increases disease risk.
It can be corrected by daily ingestion of supplements or fortifi cation
Discussion
Kevin D. Cashman Calcium and vitamin D
Discussion
Jan Alexander Selenium
Discussion
Edzard Ernst Herbal medicines: balancing benefi ts and risks
Discussion
E. L. Yong, S. P. Wong, P. Shen, Y. H. Gong, J. Li and Y. Hong
Standardization and evaluation of botanical mixtures: lessons from a
traditional Chinese herb, Epimedium, with oestrogenic properties
Discussion
Hildegard Przyrembel Communication between science and
management
Discussion 199
Paul M. Coates Dietary supplements and health: the research agenda
Discussion
Final discussion w-3 fatty acids
Index of contributors
Subject index